Literature DB >> 7921439

Quantification of hemodynamics in primary pulmonary hypertension with magnetic resonance imaging.

A A Tardivon1, E Mousseaux, F Brenot, J Bittoun, O Jolivet, E Bourroul, P Duroux.   

Abstract

The aims of this study were first to analyze pulmonary flow differences between patients with primary pulmonary hypertension (PPH) and volunteers, and second to determine whether magnetic resonance (MR) 3D Fourier encoding velocity imaging is capable of assessing hemodynamics in PPH. Pulmonary and aortic flows were quantified with MR imaging in 13 patients with PPH confirmed by right heart catheterization (RHC) within the same week and in 10 volunteers. MR pulmonary antegrade velocities, acceleration time (defined as the time from the onset of flow to the peak velocity), and arterial distensibility (maximal surface-minimal surface/minimal surface) were significantly different in patients (p < 0.05). MR pulmonary and aortic flow volumes correlated well with each other in the two populations (r = 0.98). Agreement between MR and RHC data was low: for the right cardiac output (mean difference) the 95% confidence interval was -0.88 to -0.22 L/min and for the right stroke volume 2.83 to 9.71 ml. However, the high coefficient correlations found between the two techniques showed that MR data could be used as indicators of right hemodynamics. 3D Fourier encoding-velocity sequence is a reliable noninvasive flow measurement method for the quantification of right hemodynamics in patients with PPH.

Entities:  

Mesh:

Year:  1994        PMID: 7921439     DOI: 10.1164/ajrccm.150.4.7921439

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Primary pulmonary hypertension.

Authors:  A J Peacock
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

2.  Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension.

Authors:  Jordan C Ray; Charles Burger; Patricia Mergo; Robert Safford; Joseph Blackshear; Christopher Austin; DeLisa Fairweather; Michael G Heckman; Tonya Zeiger; Marcia Dubin; Brian Shapiro
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-22       Impact factor: 2.357

3.  Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling.

Authors:  Jan Skrok; Monda L Shehata; Stephen Mathai; Reda E Girgis; Ari Zaiman; James O Mudd; Danielle Boyce; Noah Lechtzin; João A C Lima; David A Bluemke; Paul M Hassoun; Jens Vogel-Claussen
Journal:  Radiology       Date:  2012-04-16       Impact factor: 11.105

4.  Phase-contrast magnetic resonance imaging for analyzing hemodynamic parameters and wall shear stress of pulmonary arteries in patients with pulmonary arterial hypertension.

Authors:  Hung-Hsuan Wang; Wen-Yih Isaac Tseng; Hsi-Yu Yu; Meng-Chu Chang; Hsu-Hsia Peng
Journal:  MAGMA       Date:  2019-07-03       Impact factor: 2.310

5.  Black blood MRI has diagnostic and prognostic value in the assessment of patients with pulmonary hypertension.

Authors:  Andrew J Swift; Smitha Rajaram; Helen Marshall; Robin Condliffe; Dave Capener; Catherine Hill; Christine Davies; Judith Hurdman; Charlie A Elliot; Jim M Wild; David G Kiely
Journal:  Eur Radiol       Date:  2011-10-13       Impact factor: 5.315

6.  Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements.

Authors:  Jean-Philippe Alunni; Bruno Degano; Catherine Arnaud; Laurent Tétu; Nathalie Blot-Soulétie; Alain Didier; Philippe Otal; Hervé Rousseau; Valérie Chabbert
Journal:  Eur Radiol       Date:  2010-01-22       Impact factor: 5.315

7.  Low WSS and High OSI Measured by 3D Cine PC MRI Reflect High Pulmonary Artery Pressures in Suspected Secondary Pulmonary Arterial Hypertension.

Authors:  Masaki Terada; Yasuo Takehara; Haruo Isoda; Tomohiro Uto; Masaki Matsunaga; Marcus Alley
Journal:  Magn Reson Med Sci       Date:  2015-11-13       Impact factor: 2.471

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.